ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

476
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Refresh
16 Feb 2016 00:59

2016 Major IPOs Pipeline in Korea - Part II

In our previous report - 2016 Major IPOs Pipeline in Korea, we identified 19 companies that are seeking to complete IPOs in Korea in 2016. In this...

Logo
232 Views
Share
12 Feb 2016 23:11

2016 Major IPOs Pipeline in Korea

This year appears to be an exciting year for IPOs in Korea, barring a dramatic downturn in global equities markets like the one we experienced in...

Logo
289 Views
Share
bearishCelltrion Inc
11 Oct 2015 04:02

The Risks of High Expectations for Biosimilars

Celltrion trades at a premium valuation (35x 2016 estimated earnings) based on high expectations for its biosimilar (copycats of biotech) products....

Share
05 Feb 2015 16:01

Introducing Long Term Leaders - Focussed Insights for your Core Holdings

We are pleased to announce the roll out of our latest content vertical: Long Term Leaders. Under this category,  we have identified companies that...

Logo
313 Views
Share
03 Oct 2023 00:27

Alpha Generation Through Share Buybacks in Korea: August & September 2023

In this insight, we discuss the alpha generation through companies that announced share buybacks in Korea in August and September 2023.

Logo
598 Views
Share
x